-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
NewAmsterdam Pharma Co N.V. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2023 to Q2 2024.
- NewAmsterdam Pharma Co N.V. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$39M, a 1.87% decline year-over-year.
- NewAmsterdam Pharma Co N.V. annual Net Income (Loss) Attributable to Parent for 2023 was -$177M, a 682% decline from 2022.
- NewAmsterdam Pharma Co N.V. annual Net Income (Loss) Attributable to Parent for 2022 was -$22.6M, a 45.8% increase from 2021.
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)